Successful Treatment of an EBV-positive Diffuse Large B-Cell Lymphoma in a Patient With Trisomy 21
- 30 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 42 (6) , e472-e474
Abstract
Diffuse large B-cell Lymphoma (DLBCL) secondary to a chronic severe Epstein-Barr virus (EBV) infection has not been previously described in a patient with trisomy 21. Here we report the case of a 14-year-old girl with trisomy 21 with impaired control of EBV and DLBCL. She was cured with dose-adapted chemotherapy and hematopoietic stem cell transplantation without severe treatment-related toxicity. We describe the first case of EBV-positive DLBCL in a patient with trisomy 21 and we propose a treatment modality for this rare entity.Keywords
This publication has 14 references indexed in Scilit:
- Long-term clinical effects of early thymectomy: Associations with autoimmune diseases, cancer, infections, and atopic diseasesJournal of Allergy and Clinical Immunology, 2018
- Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescentsHaematologica, 2016
- Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with theAIEOP LNH‐97 protocolBritish Journal of Haematology, 2016
- Decreased Thymic Output Accounts for Decreased Naive T Cell Numbers in Children with Down SyndromeThe Journal of Immunology, 2011
- Infections and immunodeficiency in Down syndromeClinical and Experimental Immunology, 2011
- Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphomaPediatric Blood & Cancer, 2009
- Acute lymphoblastic leukemia and Down syndromeCancer, 2008
- The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in lifeClinical and Experimental Immunology, 2004
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- Risks of leukaemia and solid tumours in individuals with Down's syndromeThe Lancet, 2000